Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 3 | 2020 | 639 | 1.250 |
Why?
|
| Vitamin D | 2 | 2020 | 180 | 1.040 |
Why?
|
| RNA, Long Noncoding | 2 | 2020 | 248 | 1.040 |
Why?
|
| Exosomes | 1 | 2024 | 57 | 0.820 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 59 | 0.810 |
Why?
|
| Histone Deacetylase 1 | 1 | 2020 | 22 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 91 | 0.650 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 177 | 0.630 |
Why?
|
| Indoles | 1 | 2020 | 202 | 0.610 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 298 | 0.560 |
Why?
|
| RNA | 1 | 2019 | 606 | 0.490 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 468 | 0.480 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 260 | 0.430 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 767 | 0.360 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1693 | 0.350 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2559 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3794 | 0.320 |
Why?
|
| Acetylation | 2 | 2020 | 196 | 0.290 |
Why?
|
| Cell Cycle | 2 | 2020 | 619 | 0.280 |
Why?
|
| Histones | 2 | 2020 | 572 | 0.230 |
Why?
|
| Endosomes | 1 | 2024 | 68 | 0.210 |
Why?
|
| Apoptosis | 2 | 2020 | 1928 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 91 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 232 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 2125 | 0.190 |
Why?
|
| Peptoids | 1 | 2021 | 8 | 0.180 |
Why?
|
| Peptidomimetics | 1 | 2021 | 13 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2021 | 55 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2021 | 61 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2019 | 945 | 0.180 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 62 | 0.170 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2020 | 25 | 0.170 |
Why?
|
| Genes, myc | 1 | 2020 | 107 | 0.160 |
Why?
|
| Calcitriol | 1 | 2020 | 79 | 0.160 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 127 | 0.160 |
Why?
|
| Cell Movement | 2 | 2021 | 906 | 0.160 |
Why?
|
| Oncogenes | 1 | 2020 | 181 | 0.160 |
Why?
|
| Imidazoles | 1 | 2020 | 218 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 351 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 218 | 0.150 |
Why?
|
| Piperazines | 1 | 2020 | 256 | 0.150 |
Why?
|
| Gene Editing | 1 | 2020 | 213 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 249 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 398 | 0.130 |
Why?
|
| Wound Healing | 1 | 2020 | 483 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 788 | 0.120 |
Why?
|
| Gene Expression | 1 | 2020 | 1608 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 829 | 0.110 |
Why?
|
| Humans | 8 | 2021 | 133331 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2877 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1849 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1558 | 0.090 |
Why?
|
| Animals | 2 | 2024 | 36217 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2017 | 1140 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2720 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1411 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 2990 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13103 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 111 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 233 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 318 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 607 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 204 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1714 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1852 | 0.030 |
Why?
|
| Female | 1 | 2020 | 71482 | 0.030 |
Why?
|